Next Article in Journal
Plant Nanovesicles for Essential Oil Delivery
Next Article in Special Issue
Multifunctional Photoactive Nanomaterials for Photodynamic Therapy against Tumor: Recent Advancements and Perspectives
Previous Article in Journal
Ramosin: The First Antibacterial Peptide Identified on Bolitoglossa ramosi Colombian Salamander
Previous Article in Special Issue
Neuropeptide-Functionalized Gold Nanorod Enhanced Cellular Uptake and Improved In Vitro Photothermal Killing in LRP1-Positive Glioma Cells
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceutics
Volume 14
Issue 12
10.3390/pharmaceutics14122580
pharmaceutics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Photo-Phytotherapeutic Gel Composed of Copaifera reticulata, Chlorophylls, and k-Carrageenan: A New Perspective for Topical Healing

by
Katieli da Silva Souza Campanholi
1,*,
Ranulfo Combuca da Silva Junior
1,
Renato Sonchini Gonçalves
2,
Mariana Carla de Oliveira
3,
Magali Soares dos Santos Pozza
4,
Angela Tiago Leite
3,
Leandro Herculano da Silva
5,
Luis Carlos Malacarne
6,
Marcos Luciano Bruschi
3,
Leandro Dalcin Castilha
4,
Tatiana Carlesso dos Santos
4 and
Wilker Caetano
1,*
1
Chemistry Department, State University of Maringá, Maringá 87020-900, PR, Brazil
2
Laboratory of Chemistry of Natural Products, Department of Chemistry, Center for Exact Sciences and Technology, Federal University of Maranhão, São Luís 65080-805, MA, Brazil
3
Laboratory of Research and Development of Drug Delivery Systems, Department of Pharmacy, State University of Maringá, Maringá 87020-900, PR, Brazil
4
Department of Animal Science, State University of Maringá, Maringá 87020-900, PR, Brazil
5
Department of Physics, Federal Technological University of Paraná, Medianeira, 85884-000, PR, Brazil
6
Physics Department, State University of Maringá, Maringá 87020-900, PR, Brazil
*
Authors to whom correspondence should be addressed.
Pharmaceutics 2022, 14(12), 2580; https://doi.org/10.3390/pharmaceutics14122580
Submission received: 15 October 2022 / Revised: 19 November 2022 / Accepted: 21 November 2022 / Published: 24 November 2022
(This article belongs to the Special Issue Design and Characterization of Functional, Light-Responsive Materials for Drug Delivery and Tissue Engineering)
Browse Figures
Versions Notes

Abstract

:
Chronic wound healing represents an impactful financial burden on healthcare systems. In this context, the use of natural products as an alternative therapy reduces costs and maintains effectiveness. Phytotherapeutic gels applied in photodynamic therapy (PDT) have been developed to act as topical healing medicines and antibiotics. The bioactive system is composed of Spirulina sp. (source of chlorophylls) and Copaifera reticulata oil microdroplets, both incorporated into a polymeric blend constituted by kappa-carrageenan (k-car) and F127 copolymer, constituting a system in which all components are bioactive agents. The flow behavior and viscoelasticity of the formulations were investigated. The photodynamic activity was accessed from studies of the inactivation of Staphylococcus aureus bacteria, the main pathogen of hospital relevance. Furthermore, in vivo studies were conducted using eighteen rabbits with dermatitis (grade III and IV) in both paws. The gels showed significant antibiotic potential in vitro, eliminating up to 100% of S. aureus colonies in the presence or absence of light. The k-car reduced 41% of the viable cells; however, its benefits were enhanced by adding chlorophyll and copaiba oil. The animals treated with the phytotherapeutic medicine showed a reduction in lesion size, with healing and re-epithelialization verified in the histological analyses. The animals submitted to PDT displayed noticeable improvement, indicating this therapy’s viability for ulcerative and infected wounds. This behavior was not observed in the iodine control treatment, which worsened the animals’ condition. Therefore, gel formulations were a viable alternative for future pharmaceutical applications, aiming at topical healing.

1. Introduction

Wounds can be classified as a disruption in the tissue architecture, acting as a gateway for microorganisms that lead to local or systemic infections. Skin lesions affect people at any age; and can have different origins, such as trauma and ulcerative dermatitis. Several types of adjunctive treatment for acute wounds are available. However, cure rates are sometimes low, due to infections caused by resistant bacteria, causing secondary infections [1,2,3]. Therefore, developing research that deals with wound therapies is fundamental for emergent international hospital clinical protocols and guidelines based on updated scientific evidence [4,5,6].
A promising approach to reduce the burden of microorganisms is photodynamic therapy (PDT) [7,8,9,10], which is widely reported in the literature and available in hospitals in first-world countries. PDT is a minimally invasive and non-toxic antimicrobial strategy for killing infectious pathogens in an efficient, faster, and independent mode, in comparison with existing antibiotics [11]. This therapy is based on the excitation of a photosensitizer (PS) molecule by a specific wavelength [12]. The PS forms a long-lived triplet state that can react with molecular oxygen to generate reactive oxygen species (ROS), including singlet oxygen and hydroxyl radicals, leading, in situ, to cell death by necrotic and apoptotic modes [13,14]. As a result, significant advantages of PDT on antimicrobial chemotherapy are observed: it offers a short inactivation time to lead to cell death pathways; it does not lead to bacterial resistance after multi-course treatment; it does not cause dysbacteriosis; and it is applied to a wide range of target microorganisms, including Gram-positive and Gram-negative bacteria [7,9,15]. The widespread use of PDT in the treatment of skin tumors, actinic keratosis, acne, and rosacea is noteworthy and recognized by the Brazilian Society of Dermatological Surgery. In terms of contraindication, PDT is not indicated for the treatment of spots, as these are the skin lesions that have some chance of becoming melanomas, and the technique cannot be used on melanomas before surgical resection [16].
Another aggravating factor in wound therapy is related to the costs that result from treatments. For example, chronic wound healing in Brazil represents an impactful financial burden on the public health system, costing up to US$ 1772.40 per person (or treatment) [17]. In some countries, the financial costs of wound products are exclusively carried by patients, as there is no public health policy to support patients [18], which encourages researchers to search for effective and low-cost therapies. A therapeutic and inexpensive approach can be achieved with natural drugs and natural polysaccharides gels. In the last decade, several studies have been published concerning chlorophylls (Chls) as an antibiotic (PS compound) in PDT [9,19,20]. The advantage of natural Chls over synthetic PS is that the raw materials are readily available and inexpensive, and the extraction techniques do not require high labor costs [19]. In addition, chlorophylls absorb in the red region, the color of greatest skin penetration, which makes them attractive for topical use. In a recent publication, we showed the potential of Chls in PDT, which caused severe damage to the cell wall Staphylococcus aureus bacteria [9]. Here, the Chls from Spirulina sp. were from a microalgae that is widely used as a source of PS in PDT [21,22].
The benefits of Chls in PDT treatment can be harnessed through emulsions containing oil drops (emulgels), which provide preferential means of PS monomerizing. In this process, copaiba oil (CO) offers advantages in skin treatment, due to its cell regeneration properties [23,24,25,26,27], as widely recognized in popular culture. CO from the Copaifera reticulata genus is rich in sesquiterpenes and diterpene compounds [28]. Their composition reveals antimicrobial [29], larvicidal [30], repellent [31], antitumor skin disease healing [32,33], as well as anti-inflammatory properties [34]. The recognition of its potential led to the classification of CO as a medicinal plant of interest to the Brazilian Public Health System (SUS) and approval by the Food and Drug Administration (FDA) as a phytotherapeutic medicine [35,36]. Our research group has shown benefits in using copaiba oil from the C. reticulata genus, a natural product of northern Brazil [37,38].
Treating skin diseases requires using pharmaceutical forms that remain for a prolonged time at the site of action [8]. Kappa-carrageenan (k-car) is a natural sulfated polysaccharide with gelling properties. K-car has gained prominence in cosmetic and pharmaceutical applications, due to its healing, bactericidal, and thermoresponsive properties [39,40]. Additionally, F127 is a triblock micellar copolymer described as poly(ethylene oxide) (EO) and poly(propylene oxide) (PO) blocks, arranged as EO99PO67EO99 [41]. F127 unimers act as permeation promoters of Copaifera reticulata Ducke [38] and lead to Chls monomerization [9,42]. Therefore, this study identifies a polymer blend with therapeutic effect through the combination of k-car polysaccharide and F127 copolymer, with the aim of providing auxiliary healing and bactericidal activity to the incorporated drugs (phytotherapeutic gels; Phy-gel).
Given the above-mentioned properties of Chls and CO, we present herein the design of a new platform-based k-car gel composed of Copaifera reticulata and Chls from Spirulina sp. as a phytotherapeutic (Figure 1) and safe alternative, with healing and antibiotic effects. Furthermore, rabbits with pododermatitis were used as a healing prototype to show the benefits of using PDT allied to Phy-CO-Chl (phytotherapeutic gel composed of copaiba oil and chlorophylls) as a new strategy for humans and for veterinary clinics.

2. Materials and Methods

The Spirulina sp. was purchased in local commerce and was used as acquired. Triethanolamine (TEA) was obtained from Synth (Diadema, São Paulo, SP, Brazil). Pluronic® F127 (MW = 12,600 g.mol−1) and k-carrageenan were purchased from Sigma-Aldrich (St. Louis, MO, USA). Brain Heart Infusion Broth (BHI) and Mueller Hinton Agar (MHA) were purchased from Himedia (São Paulo, SP, Brazil) and KASVI® (São José dos Pinhais, PR, Brazil), respectively. All experiments were carried out using ultra-pure water obtained from a Milli-Q system (Millipore, Merck, Darmstadt, Germany).

2.1. Copaifera reticulata Obtention

Copaiba oil-resin (Copaifera reticulata) was collected from geographic coordinates of −2.90344444 latitude and −49.47841667 longitude in the southwest of Pará state, Brazil. The management respected the ecosystem and sustainability of Amazonian biodiversity. The copaiba oil was extracted using a 1-inch hand drill for mechanical turning. The oil was extracted from holes drilled into the trunks of trees with a circumference greater than 1.20 m. The average collection was up to 1 L of oil resin from a selected tree, respecting the plant’s capacity. The hole was closed immediately after collection, remaining in this condition for 3 years, when a new collection in the same tree became viable [38].
The natural products were registered in the National Biodiversity Authorization and Information System (SISBIO nº 72922-1) and in the National System for Genetic Heritage Management (SISGEN nº A4F3A99).

2.2. Preparation of Gel Formulations

The gels were prepared using the previously reported methodology [43]. K-car and F127 copolymer (Table 1) were solubilized in purified water and homogenized using a mechanical stirrer for 20 min. Subsequently, Spirulina sp. (with or without CO) was added slowly into the polymeric pharmaceutical excipient. After complete homogenization, the formulation was kept refrigerated and protected from light. Formulations in the absence of CO and Spirulina sp. were also obtained, as shown in Table 1. The gel formulation, inserted in a glass bottle, was kept at rest for 24 h at 5 °C before further analysis.

2.3. Texture Profile Analysis

The texture assessments were conducted at 32 ± 2 °C (skin temperature) on the texture profile analysis (TPA). The emulgels’ mechanical properties were determined using TA-XTplus Texture Analyzer (Stable Micro Systems, Surrey, England), with a cylindrical probe (10 mm the diameter) moving at 2 mm.s−1. The probe performed two compressions, with 15 s of rest between them. Based on these measurements, charts displaying force values and displacement of the capital were obtained, which were used for determining the gel hardness, adhesiveness, cohesiveness, elasticity, and compressibility. The hardness (N) was obtained on the first positive peak maximum force. The elasticity (mm) was expressed by the quotient of the second/first peak. Cohesiveness was expressed by the quotient of the surface area under the first peak under the second positive peak. Adhesiveness corresponded to the surface area of the first negative. All the measurements were performed in at least six replicate samples for each formulation. The results are expressed as the mean ± standard deviation.

2.4. Rheological Analysis

The rheological properties of the dermatological emulgel were studied in a HAAKE MARS II rheometer (Thermo Fisher Scientific, Karlsruhe, Germany). The system was equipped with a parallel steel cone-plate geometry of 35 mm separated by a gap of 0.052 mm (cone code L09006 C60/1° Ti L). The gel was carefully applied to the lower plate, and the rheological profile information was collected after 1 min of stabilization. Continuous shear (flow) rheometry was investigated, with shear rates from 0 to 2000 s−1. The upward curve profiles were generated in a progressive increase in the shear rate up to 150 s, kept at the upper limit for 10 s, and progressively decreased throughout 150 s. Ostwald–de Waele and Herschel–Bulkley equations were used to adjust the replicated ascending flow curves, which obtained the values of consistency index (K), flow behavior (n), and yield value (σy). The assessments were conducted at 32.0 ± 0.1 °C for at least three replicates.
The gel’s oscillatory performance evaluations were conducted in the interval of frequency sweep from 0.1 to 10.0 Hz, inside the linear viscoelastic region (LVR), in a condition of fixed stress. In this process, the parameters of dynamic viscosity (η’), storage modulus (G’), loss modulus (G”), and loss tangent (tan δ) were obtained using RheoWin 4.10.0000 (Haake®) software. The measurements were performed at 32.0 ± 0.1 °C. The elastic modulus (G’), the loss modulus (G”), the dynamic viscosity (η’), and the loss tangent (tan δ) were determined using RheoWin version 4.10.0000 (Haake®).
The stimuli-sensitive evaluation of systems was carried out by temperature ramp (from 5.0 to 60.0 °C), with a heating rate of 10 °C min−1. The analyses were conducted with a frequency of 1.0 Hz at LVR. All rheological analyses were performed using at least three replicates.

2.5. Photodynamic Evaluation

The photodynamic Spirulina sp. potential was performed by a qualitative method. The analyses were conducted using an ethanolic solution containing Spirulina sp. 4 mg/mL and 29 μmol/L of uric acid (UA). Uric acid is a chemical probe, and it degrades as PDT progresses. This solution was placed in a quartz cuvette and evaluated by collecting electronic absorption plots as a function of illumination time. The irradiation process for chlorophylls photoexcitation was carried out by a set of 6 red LED (5 mm model, λmax = 632 nm, 12.5 mW), positioned evenly on the sides of the sample port of the spectrophotometer equipment UV-Vis (Varian, Cary 50 model), as previously reported [9]. The spectrophotometer works with modulated phase radiation, which allows the external red light to not influence the measurements.

2.6. Bacterial Photodynamic Inactivation: In Vitro Assays

2.6.1. Microorganism Preparation

The Staphylococcus aureus (ATCC 25923) bacteria were activated in BHI broth. Before each experiment, the bacteria were replicated for two consecutive days and incubated at 37 °C for 24 h. The cell density was standardized in tubes containing a 0.9% sterile saline solution, and the McFarland scale was used for turbidity equivalence, corresponding to 108 colony-forming units (CFU)/mL.

2.6.2. Photodynamic Inactivation of S. aureus Performed by Chlorophylls Gel

First, as we previously reported, 1 mL of Mueller–Hinton broth and 3 g of phytotherapeutic emulgel were distributed in 12-well plates [44]. Next, the mixture was homogenized using a sterile tip. Then, 100 μL of the S. aureus suspension was added to each plate. The 12-well plates obtained, which had Phy-Chl and Phy-CO-Chl, were illuminated for 30 min with red LED (1.2 mw/cm2 with a light dose of 2.15 J/cm2, Figure 2). After illumination, 1 mL was collected from the well plates and added to Petri plates containing MH agar for subcultivation for 24 h at 37 °C. Finally, the controls were performed considering only bacteria, illuminated bacteria with red LED, Phy-Chl, and Phy-CO-Chl in the dark. After incubation, the total bacterial count, in CFU/mL, was determined [44,45].

2.7. Pododermatitis Treatment: In Vivo Assays in Rabbits

The study was previously submitted to the ethics committee on the use of animals, with approval under protocol 2268101221. All procedures performed in the study followed the international, national, and/or institutional guidelines for the care and use of animals. The animal experiment was carried out in the rabbit-farming sector of the Iguatemi Experimental Farm at the State University of Maringá.

2.7.1. Animal Model

Rabbits (male and female between 2 and 3 years old, weighing approximately 3.5 kg and with paw lesions of grade III and IV) were used. Grade III lesions contain the presence of small scabs, sores, and moderate pain. Grade IV lesions contain infected wounds, with the presence of secretion and blood. The rabbits’ lesions were caused accidentally by the friction of the paws (without pads) in the breeding cages. Three animals per treatment, with lesions on both legs, were used (n = 6, considering the leg numbers). The initial dimensions for the Phy-gels treatment groups ranged from 1.20 to 3.1 cm. The group of control animals showed lesions between 0.54 and 1.98 cm. The treatment groups are shown in Table 2.

2.7.2. Procedures

The animals were treated for 21 days with daily administrations of around 1 g of emulgel in each paw. The lesions were monitored every seven days and measured (diameter of lesions, Øday), with pictures using ImageJ software. These results were expressed as a percentage of contraction, determined by 1 − [ ( ∅ 21 ∗ 100 ) /   ∅ 1 ] .
The animals in the illuminated group were subjected to red light for 10 min. The lighting system was attached to the cages at a distance of 2.5 cm between the light and the animal. Red LED system (660 nm) was used as a flat platform (Figure 3), with a potential difference of 20.0 ± 0.5 V and the current i = 1.0 ± 0.1 A.

2.7.3. Characteristics of the Lighting System

The lighting system was designed for animal application. The irradiance was measured at the height of 2.5 cm for 4 different positions in the central region of the plate. The result shows an average irradiance I = 5.6 ± 0.2   mW / cm 2 . At room temperature, the emission spectrum of the LED system was obtained using the UV-Visible Spectroradiometer System equipment of Gooch & Housego PLC, which was certified by the National Institute of Standards and Technology (NIST). The measurements provided the emission spectra from 250 nm to 800 nm wavelengths, and the integration method was used to obtain emission intensity values. The lighting system provided irradiance proportional to the current used (Figure 4) and the high spectral overlapped the absorption profile of the chlorophylls contained in Spirulina sp.

2.8. Histological Analysis

On the 21st day, one animal from each treatment was sent to the university abattoir after solid fasting (12 to 18 h). Slaughter occurred by electrical stunning and subsequent bleeding, following the current legislation for humane slaughter (Resolution n° 1000/2012 of the Federal Council of Veterinary Medicine, under Directive n° 47/2013 from Ministério da Agricultura, Pecuária e Abastecimento). During the slaughter procedures, the feet were separated and samples from the wound area were collected for histological analysis (both paws). Samples were fixed by immersion in 10% w/v formalin and processed by routine histological procedures to include samples in paraffin blocks [46]. Paraffin bocks were cut (3 µm) using an American optical 820 model microtome, and the slides were stained by hematoxylin-eosin (HE). The slides were analyzed via a Kasvi/Motic microscope with Motik Image proplus 2.0 software.

2.9. Statistical analysis

The averages were compared using the free software R, version 3.6.0, with the R studio interface, version 1.1.463 [47]. The statistical test was applied to compare the effect of C. reticulata and Spirulina sp. on the carrageenan gel properties in the oscillatory rheological behavior (at representative frequencies: 0.316, 1.000, 3.162, and 10.000 Hz), flow index, consistency index, hysteresis area, yield value, hardness, compressibility, adhesion, elasticity, and cohesiveness parameters. The significance level to reject the null hypothesis was 5% (p < 0.05).

3. Results and Discussion

Biopolymers for targeted drug delivery have been explored in many studies to develop the ideal dermatological biomedical platform. Carrageenans are sulfated biocompatible polysaccharides with prominent relevance in medicinal chemistry, pharmaceutical applications, and biotechnological research [48]. The k-car sulfate groups and F127 unimers offer polar and apolar environments for Chls monomerization. Furthermore, the combination of these polymers confers viscosity and adequate interfacial tension to avoid the coalescence processes of the CO droplets. The following analyses highlight the physical, rheological, microbiological, and curative aspects of phytotherapeutic gels (Phy-gels), with potential uses in human and veterinary medicine.

3.1. Physical and Chemical Aspects

The Phy-gels were homogeneous, opaque and did not separate phases throughout the experiment. The Spirulina sp. had a high concentration of Chls a and b (and their derivatives compounds), with an intense Q-band in the red region, between 645 and 695 nm (Figure 5A). The high concentration of chlorines showed photodynamic activity, a fact verified by the degradation of uric acid (UA, chemical probe) after activating the Chls compound. UA had a band at 294 nm and no bands in the visible region. The reduction of around 40% at 294 nm was related to the formation of reactive oxygen species formed after the light-activated Chls undergoes the process of inter-system conversion [8,9]. As shown in Figure 5B, the molecular oxygen in the ground state has a triplet state (3∑g). It has two low-lying singlet excited states, the 1∆g (first excited state) and 1∑g (second excited state), which differ in their electronic configuration of the π-antibonding orbitals. The transition from the 1∆g state to the 3∑g state is forbidden, leading to a long lifetime for the 1∆g state [49]. On the other hand, the second excited state (1∑g) is short-lived, due to its permitted transition to the 1∆g state. Most PDT compounds produce singlet oxygen (type II mechanism), which can oxidize the nearby biological species, such as lipids, amino acids, and DNA, due to the high reactivity of the unoccupied π 2 p * from singlet oxygen. Type I mechanisms also occur (forming O2•−, •OH, H2O2), but with lower quantum yields. In the UA assays, all formed reactive oxygen species allowed its degradation, ensuring spirulina’s potential as a PS source in PDT. In addition to the decay of the UA band, the Chls absorptions were reduced by 24% due to photobleaching—chlorophyll degradation caused by radical species formed in PDT mechanisms [50,51].
After checking the in vitro photodynamic potential, the Spirulina sp. was combined with C. reticulata to obtain Phy-gels (Figure 6). Carrageenan is a known healing agent that acts as a structuring agent [52,53]. Pluronic® F127 has been added in small amounts so that its unimers act as monomerization agents for hydrophobic PS, as previously shown [8,42]. Furthermore, F127 acts as a promoter of cutaneous permeation of C. reticulata, as we have recently shown [38].
The emulsions can be expressed by Gibbs free energy (ΔG), described by ΔG = ΔAγ-TΔS, being γ, the droplet interfacial tension, and ΔS, the entropy. The physical gel stability indicates that the cross-linked polymer (k-car) and the F127 polymeric surfactant reinforced the droplet copaiba oil interface, preventing coalescence in short periods. The smaller the droplet size, the better the thermodynamic stability the system acquires, according to Laplace’s law [54,55]. Therefore, the employment of a significant amount of energy to obtain small droplets is essential during manufacturing. The microstructure analysis of Phy-CO-Chl gel showed well-delimited interfaces and an accumulation of F127 on the drop’s surface (the lighter region in Figure 6). For the Phy-CO-Chl emulgel, 50% of the droplets were up to 10 μm in size [56]. We previously showed that Chls [8] and copaiba oil [38] have enhanced skin permeation with F127 micelles, reaching the dermis after 30 min of topical administration.

3.2. Mechanical and Rheological Properties

The rheological and textural studies can estimate the suitability of the gel platforms under industrial manufacture and also in environmental and physiological body conditions [38]. The data from the textural mechanical analysis are displayed in Table 3.
The hardness values reflect the force required to produce deformation in the semi-solid system. The gels exhibited a reduction in this parameter with the CO and Spirulina sp. addition (p < 0.05), due to the influence on the polymeric chain interactions [10]. The adhesiveness property may indicate the potential interaction of formulation with the skin after administration. The Phy-gels showed variations without statistical significance (p > 0.05) for this parameter. However, all systems proved to be an adhesive interface, an essential feature for wound closure at joints and other moving parts. The compressibility showed significant reduction (p < 0.05), with Chl components and variations without statistical relevance after CO addition (p > 0.05). Cohesiveness and elasticity are related to the ability of the system to restructure after successive deformations. For these parameters, no significant changes were verified with the variation of the formulation’s composition (p > 0.05). Furthermore, all gel formulations showed property values that were similar to those of commercial products consolidated in the market, as previously reported (Table 4) in other studies about k-car gels [57,58].
After knowing the gel’s mechanical properties, the flow rheograms were investigated. Rheological studies can characterize the flow behavior of a formulation and allow the understanding of the structuring and interactions between the components of the gel. The continuous flow rheograms are shown in Figure 7.
The flow rheograms (Figure 7A, B) showed the non-linear relationship between the applied shear stress (τ) and the shear rate (velocity gradient in reciprocal time units—ẏ). In this process, the viscosity coefficient represents the proportionality relationship between the τ and the ẏ. Its values (angular coefficient) were higher at lower oscillatory frequencies and became lower as the shear rate progressed. The viscosity reduction shown in Figure 7 resulted in an n exponent (flow behavior index) <1, and the gel can be classified as a non-Newtonian and pseudoplastic system [8,61,62]. This conduct can be explained by the high entanglement and friction of the k-car and F127 chains in the resting state, which allow higher apparent viscosity. However, the application of tension leads to the alignment of the polymer chains, which reduces viscosity. Its behaviors are typical of semi-solid systems [8,63]. The incorporation of Spirulina sp. (Phy-Chl and Phy-CO-Chl, as shown in Figure 7B) reduced the overall viscosity of the system; data concordant with structural change showed in the textural parameters (Table 3), which may be linked to reduced interaction between the polymer and polysaccharide chains. The CO effect, which remains restricted to the micellar core as a droplet, increased the global viscosity of the Phy-CO gel, an effect already verified for C. reticulata-loaded in semi-solid systems [38]. The application of shear stress forces to the Phy-CO gel allows the unraveling of chains and reduces the droplet size to the critical rheological point, which reduces overall viscosity [38,64,65,66]. Most of the flow rheograms showed no hysteresis area, except the Phy-CO gel, which presented little thixotropy, due to the oil droplets. The Phy-CO-Chl gel showed rheopexy indicative (negative hysteresis area), due to the finite time nature of the analysis.
The Ostwald–de Waele and Casson equations modeled the upward curves for statistical analyses. A flow behavior index (n) below unity was obtained (n from 0.32 to 0.40 values for all systems, as shown in Table 5) and showed an increase with the drug incorporation (p < 0.05). Furthermore, the consistency index (K) and the yield value (σy) decreased up to 50% with the Chls addition, and up to 19% with the CO incorporation (p < 0.05). The σy values indicated the need for a prior force to start the lamellar flow. The data obtained for this parameter were typical of semi-solid systems and indicated an adequate capacity of the gel to remain at the site of action, in addition to the preventive capacity to destroy the structure of the emulsion (coalescence of the droplets) [67]. Campanholi et al. (2022) [38] showed complex rheograms from Copaifera reticulata Ducke in drug-delivery systems for topical use (blends of F127 and carbopol C934P). The complex nature and difficulty of upward curve modeling were attributed to the complexity of the gel structure, which suffered constant effects of the droplet redistribution during shear.
The thermoresponsive nature of the k-car was also subjected to oscillatory analysis (Figure 8). The CO and Chls incorporation into Std-gel led to an increase of the G’ (elastic) and G” (viscous) moduli at all temperatures, a behavior already reported for carrageenan [68]. In addition, the systems showed viscoelastic behavior (G’ > G”), with a pronounced viscosity reduction above 45 °C. Therefore, the thermo-responsive properties of these compositions can be advantageous in the gel-preparation step, which can be more easily obtained at 45 °C. However, with the administration process, the temperature variation (7 °C) does not substantially change the behavior of the formulation, as shown in Figure 8B.
Regarding oscillatory rheometry, an analysis within the linear viscoelastic region (fixed stress values ranging from 2.5 to 8 Pa, depending on the formulation) was employed at skin temperature (32 °C) (Figure 9). This region allows infinitesimal deformation, and the biopolymer chains are kept close to equilibrium. Thus, the oscillatory responses showed molecular-level interaction information. The viscoelastic properties were verified by obtaining the G’ and G” moduli. Their relationship, expressed as G”/G”, showed viscoelastic behavior when the values were less than one. In this condition (G”/G’ < 1 ), there was a predominance of elastic interactions and of reversible nature [69].
The viscoelastic behavior was dependent on composition and frequency. The CO and Chls incorporation (Phy-CO and Phy-Chl) did not significantly affect the G’ modulus (p > 0.05). On the other hand, the Phy-CO-Chl obtention increased the G’ modulus in a pronounced way, especially at the highest frequencies (p < 0.05). The G” modulus showed slight increases in the following order: Std-gel, Phy-CO, Phy-Chl, and Phy-CO-Chl. Nevertheless, the increases were not statistically significant (p > 0.05). The viscous moduli increase was of greater magnitude than the elastic moduli increase, thus enhancing the plastic characteristic of the formulations. An elastic deformation nature may be related to drug/copolymer interaction, while plastic deformations may be related to changes in the helical conformation of the k-car biopolymer. The dynamic viscosity was reduced with small movements (low oscillatory frequencies). However, above 6 Hz, the variation was less pronounced. The gel composition did not cause significant changes in the dynamic viscosity (p > 0.05).
The tangent loss, expressed as tan δ (G”/G’), decreased with the oscillatory frequency increase (p < 0.05) for all systems. The enhanced viscoelasticity followed the complexity of the matrix composition, where Phy-CO-Chl showed tan δ of 0.259, a nearly two-fold increase compared with that of Std-gel. All formulations had tan δ values lower than one (Figure 9D), and were classified as viscoelastic systems. This is an essential property when considering drug-delivery systems, as it suggests an appropriate retention of these formulations at the application site [63,69,70,71,72,73,74].

3.3. Photodynamic Inactivation of Staphylococcus Aureus Bacterial

Wound healing involves three major phases: inflammatory reaction, cell proliferation, and remodeling. First, the inflammatory process occurs with vasoconstriction, hemostasis, and inflammatory mediator release. Then, the granulation tissue is triggered, with fibroblast proliferation and angiogenesis effects. At this point, opportunistic pathogens, such as Staphylococcus, infect small dermal lesions and invade subcutaneous tissue [46,75,76]. Therefore, inactivation studies of these pathogens are fundamental to evaluate the healing and antibiotic potential of the drug. The antibacterial activity of Phy-gels against S. aureus is presented in Figure 10.
Bacterial cell incubation with gels led to statistically significant count reductions of the colony-forming units (CFU) (p < 0.05). The Std-gel showed bacterial potential, with a countdown of 41%, a similar result to that previously reported [77]. The Chls incorporation further reduced the count of viable cells count (p < 0.05). The Phy-Chl activity without light showed a 30% CFU reduction, and this value increased to 37% after light. The CO addition into the matrix gel increased the potential of the formulation, allowing the total elimination of all viable cells in the light and in the dark. This pronounced increase was probably related to the bactericidal behavior of the CO and its influence on the Chls additional monomerization capacity. The interface-defined droplets can solubilize hydrophobic PS in their microdomains, a known behavior for emulgels with hydrophobic compounds [67]. The higher rate of monomers increases the number of molecules able to undergo intersystem conversion, so that singlet oxygen (the PDT protagonist) is formed.
Although in vitro treatment suggested efficiency in the absence of light for the Phy-CO-Chl gel, photodynamic treatment is essential, because Chls inhibit the resistance effect on pathogens by generating singlet oxygen. At the same time, CO acts as a wound-healing agent [9,37,38,44,78]. We have previously shown severe damage that low concentrations of Chls can cause to the bacteria wall, making its efficiency in PDT unquestionable [9]. Moreover, the literature reports that red wavelength LED significantly enhanced the skin graft score, which increased the transforming growth factor beta (TGF-β) protein expression and the density of collagen fibers [79]. Therefore, at the same time as the drugs act, red LED enhances the dermo–epidermal junction and modulates the expression proteins related to tissue repair [79].
The combined mechanical, rheological, and photo-antimicrobial benefits encouraged in vivo studies on animals with wound lesions.

3.4. Photodynamic Treatment: In Vivo Assays in Rabbits

The benefits of carrageenan and copaiba oil in wound healing are already known [48,80,81,82], but not widely reported with the addition of Chls.
The lesion shrinkage is shown in Table 6. The values, measured at 7 day intervals, were expressed in percentages, considering the first and last day of the treatment. The mean shrinkage value of the wounds treated with the formulations varied between 59.5% and 100%.
The lesion contraction effect between the groups treated with Phy-gels was statistically similar (p > 0.05), but different from that of the iodine treatment (p < 0.05). For lesions submitted to the control treatment, 80% showed an increase in lesion severity, and only 20% had their lesions reduced by up to 37%. Although the phytotherapeutic treatments (light and dark) were equivalent, the PDT reduced the pathogen load without generating bacterial resistance effects, which inhibited the systemic level of infection or the development of chronic wounds [7,9,10].
The worsening of the clinical condition of the iodine-treated animals can be seen in the macroscopic images of the rabbits’ feet and their respective histologies (Figure 11).
The histology in Figure 11 showed a similarity between the histology of the iodine-treated (Figure 11B) and the untreated animals (Figure 11C). Injuries tissue (Figure 11A), vasodilatation, and migration of inflammatory cells to the lesion region, due to the attraction of chemopathic molecules, can be verified (Figure 11B and Figure 11C). Furthermore, there was an increase in space between the connective tissue cell fibers, due to the increased interstitial fluid resulting from edema, as described by other authors [80,83].
The treatment with Phy-gel was more effective than that of the control. In all cases treated with Phy-gel, the healing progression was concordant with the initial degree of wound healing.
The Phy-CO formulation showed almost complete healing by the 21st day. However, the epithelium was still thick, with a thin keratin layer. The dermis was in a phase of organization, while the hair follicles were organized, with signs of hair emergence [46]. However, as seen in the Figure 12, healing was not complete, and inflammatory cells were still found in specific segments, with blood containing leukocytes accumulating (Figure 12). The benefits of CO as a healing and anti-inflammatory agent have already been reported in oral or topical administration [25].
The treatment with Phy-Chl (dark) favored healing, which was maintained on 21st day with only slight edema (Figure 12). The treated lesion tissue showed intact epithelium, with reorganized dermis and hair follicles. Moreover, fur began to develop and emerge. There are few studies on the healing capacity of Chls [84,85], with a few occurring in the 1950s. The results presented here support the potential for combining Chls and k-car. The Phy-Chl treatment showed more promise than Phy-CO for the tested treatment interval.
Phy-CO-Chl (Figure 13) treatment showed edema at the end of treatment, with the presence of inflammatory cells in the dermis region, broken follicles, and the presence of blood accumulation due to the effect of vasodilation. The treatment variations (all Phy-gels in dark conditions) were linked to deep lesions and animal management, as the animals were kept in cages during treatment, which made healing difficult due to the constant friction of the feet in the cages. Overall, the treatments showed benefits of the Phy-gels (without the use of PDT) for healing, even if the benefits were incomplete (an increase in the frequency of dosage or treatment time could lead to complete healing). On the other hand, the treatment with iodine worsened the condition of all animals. The results obtained in the dark were similar to those reported by Plefh et al. (2021) [46], who evaluated 21 day treatments with a fluid gel containing 2% of clove powder (Syzigium aromaticum), as antimicrobial, antioxidant, and anti-inflammatory properties on wounds (pododermatitis) of rabbits.
PDT use in pododermatitis cases aims to reduce the pathogen load. Furthermore, the short lifetime of singlet oxygen does not allow antimicrobial resistance [7,9,86]. The activation of the photochemical and photophysical mechanisms was possible due to the overlap of the chlorophyll absorption spectrum (Q-band at 670 nm) with the emission from the red source (660 nm). The evolution of the lesions submitted to PDT is shown in Figure 14.
Phy-Chl+PDT showed superior healing signs, with the regeneration of the dermal papillae and the formation of a thick keratin layer. Furthermore, the treatment favored the regeneration of the epithelium, which was intact on the last day of treatment. Similarly, the Phy-CO-Chl+PDT exhibited a process of reepithelization in addition to the formation of fur. Furthermore, the presence of a crust was verified in the lesion region (according to the 21st day photograph, as shown in Figure 14), indicating that the healing process was still in progress [48,80]. The improvement in the results is linked to the tissue-recovery capacity stimulated by the red light, which is associated with the reduction of the pathogen loads that cause infection (Figure 10). In addition, the benefits of using red light in the reepithelialization process are known, with light being a treatment mechanism (photobiomodulation to improve immune system function) [87,88,89].

4. Conclusions

The chlorophyll from Spirulina sp. showed photodynamic activity by degrading uric acid in a homogeneous medium (ethanol). The gel composed of Spirulina sp. and Copaifera reticulata exhibited evident bactericidal capacity, as it caused the death of 100% of S. aureus, whether in the presence or absence of photodynamic therapy. Moreover, the phytotherapeutic gels were viscoelastic, adhesive, cohesive, and pseudoplastic, being essential for drug-delivery topical systems. In vivo studies proved the potential for phytotherapeutic gels, showing a lesion contraction effect with evidence of healing and reepithelialization in histological analyses. The use of iodine (control) worsened the clinical picture of the animals, with pronounced enlargement of lesions and signs of severe infections. Therefore, the gel formulation associated with photodynamic therapy showed satisfactory potential, representing a viable alternative for pharmaceutical applications aimed at topical healing.

Author Contributions

K.d.S.S.C.: Conceptualization, methodology, formal analysis, investigation, and writing—original draft preparation; R.C.d.S.J.: methodology; R.S.G.: writing—original draft preparation; M.C.d.O.: methodology; A.T.L.: methodology; L.H.d.S.: methodology and formal analysis; L.C.M.: methodology and formal analysis; T.C.d.S.: data curation; M.S.d.S.P.: supervision and project administration; M.L.B.: data curation; L.D.C.: supervision and data curation; W.C.: supervision and project administration. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the National Ministry of Health (the Secretariat of Science, Technology and Strategic Inputs (SCTIE) and the Department of Science and Technology (DECIT)) and by Brazilian funding agencies, including CNPq (the National Council for Scientific and Technological Development) through contract 405967/2018-7, CAPES (Coordination for the Improvement of Higher Education Personnel) process 88887.286821/2018-00, FINEP (Financier of Studies and Projects), and the Araucária Foundation/PR, UGF-SETI/PR.

Institutional Review Board Statement

The study was conducted following the Declaration of Helsinki and approved by the Ethics Committee of the State University of Maringá, with approval under protocol 2268101221 for studies involving animals.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

We thank the team of collaborators of the Experimental Farm of the State University of Maringá, who provided the opportunity for this study.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Devriendt, N.; de Rooster, H. Initial Management of Traumatic Wounds. Vet. Clin. North Am. Small Anim. Pract. 2017, 47, 1123–1134. [Google Scholar] [CrossRef]
  2. Milne, K.E.; Penn-Barwell, J.G. Classification and Management of Acute Wounds and Open Fractures. Surgery 2020, 38, 143–149. [Google Scholar] [CrossRef]
  3. Fernández, J.; Ruiz-Ruiz, M.; Sarasua, J.-R. Electrospun Fibers of Polyester, with Both Nano- and Micron Diameters, Loaded with Antioxidant for Application as Wound Dressing or Tissue Engineered Scaffolds. ACS Appl. Polym. Mater. 2019, 1, 1096–1106. [Google Scholar] [CrossRef]
  4. Wynne, M. National Wound Management Guidelines. Health Serv. Exec., 2018, 366. Available online: https://healthservice.hse.ie/filelibrary/onmsd/hse-national-wound-management-guidelines-2018.pdf. (accessed on 20 November 2022).
  5. Edwards, H.; Gibb, M.; Finlayson, K.; Jensen, R. Wound Dressing Guide—Promoting Healthy Skin; 2013; ISBN 9781921897795. Available online: https://research.qut.edu.au/ccm/wp-content/uploads/sites/92/2020/04/24353_Wound-dressing-guide.pdf. (accessed on 20 November 2022).
  6. Swanson, T.; Angel, D. International Wound Infection Institute Wound Infection in Clinical Practice Update Principles of Best Practice. Wounds Int. 2022, 24, 1–59. [Google Scholar]
  7. Junior, R.C.D.S.; Campanholi, K.D.S.S.; de Morais, F.A.P.; Pozza, M.S.D.S.; dos Santos, G.T.; Hioka, N.; Caetano, W. Development and Applications of Safranine-Loaded Pluronic® F127 and P123 Photoactive Nanocarriers for Prevention of Bovine Mastitis: In Vitro and in Vivo Studies. Dye. Pigment. 2019, 167, 204–215. [Google Scholar] [CrossRef]
  8. Campanholi, K.D.S.S.; Braga, G.; Da Silva, J.B.; Da Rocha, N.L.; De Francisco, L.M.B.; De Oliveira, L.; Bruschi, M.L.; De Castro-Hoshino, L.V.; Sato, F.; Hioka, N.; et al. Biomedical Platform Development of a Chlorophyll-Based Extract for Topic Photodynamic Therapy: Mechanical and Spectroscopic Properties. Langmuir 2018, 34, 8230–8244. [Google Scholar] [CrossRef]
  9. Campanholi, K.D.S.S.; Jaski, J.M.; Junior, R.C.D.S.; Zanqui, A.B.; Lazarin-Bidóia, D.; da Silva, C.M.; da Silva, E.A.; Hioka, N.; Nakamura, C.V.; Cardozo-Filho, L.; et al. Photodamage on Staphylococcus Aureus by Natural Extract from Tetragonia Tetragonoides (Pall.) Kuntze: Clean Method of Extraction, Characterization and Photophysical Studies. J. Photochem. Photobiol. B Biol. 2020, 203, 111763. [Google Scholar] [CrossRef]
  10. da Silva-Junior, R.C.; Campanholi, K.D.S.S.; de Morais, F.A.P.; Pozza, M.S.D.S.; de Castro-Hoshino, L.V.; Baesso, M.L.; da Silva, J.B.; Bruschi, M.L.; Caetano, W. Photothermal Stimuli-Responsive Hydrogel Containing Safranine for Mastitis Treatment in Veterinary Using Phototherapy. ACS Appl. Bio Mater. 2020, 4, 581–596. [Google Scholar] [CrossRef]
  11. Kashef, N.; Huang, Y.-Y.; Hamblin, M.R. Advances in Antimicrobial Photodynamic Inactivation at the Nanoscale. Nanophotonics 2017, 6, 853–879. [Google Scholar] [CrossRef] [Green Version]
  12. Agostinis, P.; Berg, K.; Cengel, K.A.; Foster, T.H.; Girotti, A.W.; Gollnick, S.O.; Hahn, S.M.; Hamblin, M.R.; Juzeniene, A.; Kessel, D.; et al. Photodynamic Therapy of Cancer: An Update. CA. Cancer J. Clin. 2011, 61, 250–281. [Google Scholar] [CrossRef] [PubMed]
  13. Robertson, C.A.; Evans, D.H.; Abrahamse, H. Photodynamic Therapy (PDT): A Short Review on Cellular Mechanisms and Cancer Research Applications for PDT. J. Photochem. Photobiol. B Biol. 2009, 96, 1–8. [Google Scholar] [CrossRef] [PubMed]
  14. Kwiatkowski, S.; Knap, B.; Przystupski, D.; Saczko, J.; Kędzierska, E.; Knap-Czop, K.; Kotlińska, J.; Michel, O.; Kotowski, K.; Kulbacka, J. Photodynamic Therapy—Mechanisms, Photosensitizers and Combinations. Biomed. Pharmacother. 2018, 106, 1098–1107. [Google Scholar] [CrossRef] [PubMed]
  15. Musetti, C.; Spagnul, C.; Mion, G.; Da Ros, S.; Gianferrara, T.; Sissi, C. DNA Targeting by Cationic Porphyrin–Ruthenium(II) Conjugates. Chempluschem 2015, 80, 158–168. [Google Scholar] [CrossRef]
  16. SBCD. Sociedade Brasileira de Cirurgia Dermatológica. Available online: https://www.sbcd.org.br/procedimentos/oncologicos/terapia-fotodinamica-pdt/ (accessed on 20 November 2022).
  17. Cortez, D.N.; Moraes, J.T.; Ferreira, I.R.; Silva, E.L.; Lanza, F.M. Custos Do Tratamento de Lesões Cutâneas Na Atenção Primária à Saúde. ESTIMA Brazilian J. Enteros. Ther. 2020, 17, 1–7. [Google Scholar] [CrossRef]
  18. Kapp, S.; Santamaria, N. The Financial and Quality-of-Life Cost to Patients Living with a Chronic Wound in the Community. Int. Wound J. 2017, 14, 1108–1119. [Google Scholar] [CrossRef]
  19. Suvorov, N.; Pogorilyy, V.; Diachkova, E.; Vasil’ev, Y.; Mironov, A.; Grin, M. Derivatives of Natural Chlorophylls as Agents for Antimicrobial Photodynamic Therapy. Int. J. Mol. Sci. 2021, 22, 6392. [Google Scholar] [CrossRef] [PubMed]
  20. Ayaz, F.; Demirbag, B.; Ocakoglu, K. Immunoactive Photosensitizers Had Photodynamic Immunostimulatory and Immunomodulatory Effects on Mammalian Macrophages. Photodiagnosis Photodyn. Ther. 2020, 32, 102034. [Google Scholar] [CrossRef] [PubMed]
  21. Martins, M.; Albuquerque, C.M.; Pereira, C.F.; Coutinho, J.A.P.; Neves, M.G.P.M.S.; Pinto, D.C.G.A.; Faustino, M.A.F.; Ventura, S.P.M. Recovery of Chlorophyll a Derivative from Spirulina Maxima: Its Purification and Photosensitizing Potential. ACS Sustain. Chem. Eng. 2021, 9, 1772–1780. [Google Scholar] [CrossRef]
  22. Saberi, S.; Khoobi, M.; Alaeddini, M.; Etemad-Moghadam, S.; Jamshidloo, R.; Mohammadpour, H.; Shahabi, S. The Effect of Photodynamic Therapy on Head and Neck Squamous Cell Carcinoma Cell Lines Using Spirulina Platensis with Different Laser Energy Densities. Photodiagnosis Photodyn. Ther. 2022, 37, 102688. [Google Scholar] [CrossRef]
  23. Quiñones, O.G.; Hossy, B.H.; Padua, T.A.; de Oliveira Miguel, N.C.; Rosas, E.C.; de Souza Ramos, M.F.; Pierre, M.B.R. Copaiba Oil Enhances in Vitro/in Vivo Cutaneous Permeability and in Vivo Anti-Inflammatory Effect of Celecoxib. J. Pharm. Pharmacol. 2018, 70, 964–975. [Google Scholar] [CrossRef] [PubMed]
  24. Júnior, J.S.d.A.; da Silva, B.S.; Moraes, T.M.P.; Kasper, A.A.M.; Sartoratto, A.; Baratto, L.C.; de Oliveira, E.C.P.; Oliveira, E.; Barata, L.E.S.; Minervino, A.H.H.; et al. Anti-Inflammatory Potential of the Oleoresin from the Amazonian Tree Copaifera Reticulata with an Unusual Chemical Composition in Rats. Vet. Sci. 2021, 8, 320. [Google Scholar] [CrossRef] [PubMed]
  25. dos Santos Menezes, A.C.; Alves, L.D.B.; Goldemberg, D.C.; de Melo, A.C.; Antunes, H.S. Anti-Inflammatory and Wound Healing Effect of Copaiba Oleoresin on the Oral Cavity: A Systematic Review. Heliyon 2022, 8, e08993. [Google Scholar] [CrossRef]
  26. Morguette, A.E.B.; Bigotto, B.G.; Varella, R.D.L.; Andriani, G.M.; Spoladori, L.F.D.A.; Pereira, P.M.L.; De Andrade, F.G.; Lancheros, C.A.C.; Nakamura, C.V.; Arakawa, N.S.; et al. Hydrogel Containing Oleoresin From Copaifera Officinalis Presents Antibacterial Activity Against Streptococcus Agalactiae. Front. Microbiol. 2019, 10, 2806. [Google Scholar] [CrossRef] [PubMed]
  27. Wagner, V.P.; Webber, L.P.; Ortiz, L.; Rados, P.V.; Meurer, L.; Lameira, O.A.; Lima, R.R.; Martins, M.D. Effects of Copaiba Oil Topical Administration on Oral Wound Healing. Phyther. Res. 2017, 31, 1283–1288. [Google Scholar] [CrossRef]
  28. de Souza, G.A.; da Silva, N.C.; de Souza, J.; de Oliveira, K.R.; da Fonseca, A.L.; Baratto, L.C.; de Oliveira, E.C.; Varotti, F.D.P.; Moraes, W.P. In Vitro and in Vivo Antimalarial Potential of Oleoresin Obtained from Copaifera Reticulata Ducke (Fabaceae) in the Brazilian Amazon Rainforest. Phytomedicine 2017, 24, 111–118. [Google Scholar] [CrossRef]
  29. Christ, R.; Santos, V.; Filippi, C.; Schneider, T.; Quintana, L.; Lopes, S.; Aurich, C.; Luehring, J.; Brandelli, A.; Almeida, R. De Antimicrobial Activity of Amazonian Oils against Paenibacillus Species. J. Invertebr. Pathol. 2012, 109, 265–268. [Google Scholar] [CrossRef]
  30. Tatiane, F.; Trindade, T.; Stabeli, R.G. Copaifera Multijuga Ethanolic Extracts, Oil-Resin and Its Derivatives Display Larvicidal Activity against Anopheles Darlingi and Aedes Aegypti (Diptera: Culicidae). Brazilian J. Pharmacogn. 2013, 23, 464–470. [Google Scholar] [CrossRef] [Green Version]
  31. Jones, S.C.; Carter, F.L.; Mauldin, J.K. Reticulitermes Flavipes (Kollar) (Isoptera: Rhinotermitidae) Responses to Extracts from Six Brazilian Woods. Environ. Entomol. 1983, 12, 458–462. [Google Scholar] [CrossRef]
  32. Ricardo, L.M.; Dias, B.M.; Mügge, F.L.B.; Leite, V.V.; Brandão, M.G.L. Evidence of Traditionality of Brazilian Medicinal Plants: The Case Studies of Stryphnodendron Adstringens (Mart.) Coville (Barbatimão) Barks and Copaifera Spp. (Copaíba) Oleoresin in Wound Healing. J. Ethnopharmacol. 2018, 219, 319–336. [Google Scholar] [CrossRef]
  33. Paiva, L.A.F.; De Alencar Cunha, K.M.; Santos, F.A.; Gramosa, N.V.; Silveira, E.R.; Rao, V.S.N. Investigation on the Wound Healing Activity of Oleo-Resin from Copaifera Langsdorffi in Rats. Phyther. Res. 2002, 16, 737–739. [Google Scholar] [CrossRef]
  34. Gelmini, F.; Beretta, G.; Anselmi, C.; Centini, M.; Magni, P.; Ruscica, M.; Cavalchini, A.; Maffei, R. GC—MS Profiling of the Phytochemical Constituents of the Oleoresin from Copaifera Langsdorffii Desf. and a Preliminary in Vivo Evaluation of Its Antipsoriatic Effect. Int. J. Pharm. 2013, 440, 170–178. [Google Scholar] [CrossRef]
  35. de Vigilância Sanitária, A.N.; de Fitoterápicos, F. 2° Edição. Farmacopéia Brasileira. 2021. Available online: https://www.gov.br/anvisa/pt-br/assuntos/farmacopeia/formulario-fitoterapico/2022-fffb2-versao-13-mai-2022.pdf. (accessed on 20 November 2022).
  36. U.S. Department of Health & Human Services; Food and Drugs Administration. Code of Federal Regulations Title 21; U.S. Department of Health & Human Services: Washington, DC, USA, 2019; Chapter I-Food and Drug Administration—3.
  37. Campanholi, K.D.S.S.; da Silva, J.B.; Batistela, V.R.; Gonçalves, R.S.; dos Santos, R.S.; Balbinot, R.B.; Lazarin-Bidóia, D.; Bruschi, M.L.; Nakamura, T.U.; Nakamura, C.V.; et al. Design and Optimization of Stimuli-Responsive Emulsion-Filled Gel for Topical Delivery of Copaiba Oil-Resin. J. Pharm. Sci. 2021, 111, 287–292. [Google Scholar] [CrossRef] [PubMed]
  38. da Silva Souza Campanholi, K.; Sonchini Gonçalves, R.; Bassi da Silva, J.; Said dos Santos, R.; Carla de Oliveira, M.; Barbosa de Souza Ferreira, S.; Vizioli de Castro-Hoshino, L.; Bento Balbinot, R.; Lazarin-Bidóia, D.; Luciano Baesso, M.; et al. Thermal Stimuli-Responsive Topical Platform Based on Copaiba Oil-Resin: Design and Performance upon Ex-Vivo Human Skin. J. Mol. Liq. 2022, 361, 119625. [Google Scholar] [CrossRef]
  39. Kadota, K.; Nogami, S.; Uchiyama, H.; Tozuka, Y. Controlled Release Behavior of Curcumin from Kappa-Carrageenan Gels with Flexible Texture by the Addition of Metal Chlorides. Food Hydrocoll. 2019, 101, 105564. [Google Scholar] [CrossRef]
  40. Chen, Y.; Song, C.; Lv, Y.; Qian, X. Konjac Glucomannan/Kappa Carrageenan Interpenetrating Network Hydrogels with Enhanced Mechanical Strength and Excellent Self-Healing Capability. Polymer 2019, 184, 121913. [Google Scholar] [CrossRef]
  41. Nawaz, S.; Carbone, P. Coarse-Graining Poly(Ethylene Oxide)–Poly(Propylene Oxide)–Poly(Ethylene Oxide) (PEO–PPO–PEO) Block Copolymers Using the MARTINI Force Field. J. Phys. Chem. B 2014, 118, 1648–1659. [Google Scholar] [CrossRef]
  42. Campanholi, K.D.S.; Gerola, A.P.; Vilsinski, B.H.; de Oliveira, L.; de Morais, F.A.; Rabello, B.R.; Braga, G.; Calori, I.R.; Silva, E.L.; Hioka, N.; et al. Development of Pluronic ® Nanocarriers Comprising Pheophorbide, Zn-Pheophorbide, Lapachol and β-Lapachone Combined Drugs: Photophysical and Spectroscopic Studies. Dye. Pigment. 2018, 157, 238–250. [Google Scholar] [CrossRef]
  43. Uchiyama, H.; Nogami, S.; Katayama, K.; Hayashi, K.; Kadota, K.; Tozuka, Y. Jelly Containing Composite Based on α-Glucosyl Stevia and Polyvinylpyrrolidone: Improved Dissolution Property of Curcumin. Eur. J. Pharm. Sci. 2018, 117, 48–54. [Google Scholar] [CrossRef]
  44. Campanholi, K.D.S.S.; Junior, R.C.D.S.; da Silva, I.C.; dos Santos, R.S.; Vecchi, C.F.; Bruschi, M.L.; Pozza, M.S.D.S.; de Castro-Hoshino, L.V.; Baesso, M.L.; Hioka, N.; et al. Stimulus-Responsive Phototherapeutic Micellar Platform of Rose Bengal B: A New Perspective for the Treatment of Wounds. J. Drug Deliv. Sci. Technol. 2021, 66, 102739. [Google Scholar] [CrossRef]
  45. de Oliveira, É.L.; Ferreira, S.B.S.; de Castro-Hoshino, L.V.; Campanholi, K.D.S.S.; Calori, I.R.; de Morais, F.A.P.; Kimura, E.; da Silva Junior, R.C.; Bruschi, M.L.; Sato, F.; et al. Thermoresponsive Hydrogel-Loading Aluminum Chloride Phthalocyanine as a Drug Release Platform for Topical Administration in Photodynamic Therapy. Langmuir 2021, 37, 3202–3213. [Google Scholar] [CrossRef]
  46. Plefh, A.C.V.; Hoshino, L.V.C.; Sato, F.; Castilha, L.D.; Santos, T.C.; Vital, A.C.P.; Matumoto-Pintro, P.T. Cloves (Syzygium Aromaticum) Fluid Gel on Healing of Pododermatitis in Rabbits. Vet. Res. Commun. 2021, 45, 293–304. [Google Scholar] [CrossRef]
  47. RStudio Team. 2015 RStudio: Integrated Development for R; Version 1.1.463; RStudio, Inc.: Boston, MA, USA, 2015. [Google Scholar]
  48. Pacheco-Quito, E.-M.; Ruiz-Caro, R.; Veiga, M.-D. Carrageenan: Drug Delivery Systems and Other Biomedical Applications. Mar. Drugs 2020, 18, 583. [Google Scholar] [CrossRef] [PubMed]
  49. Lakowicz, J.R. Principles of Fluorescence Spectroscopy Principles of Fluorescence Spectroscopy; Springer: Berlin/Heidelberg, Germany, 2006; ISBN 978-0-387-31278-1. [Google Scholar]
  50. Gerola, A.P.; Semensato, J.; Pellosi, D.S.; Batistela, V.R.; Rabello, B.R.; Hioka, N.; Caetano, W. Chemical Determination of Singlet Oxygen from Photosensitizers Illuminated with LED: New Calculation Methodology Considering the Influence of Photobleaching. J. Photochem. Photobiol. A Chem. 2012, 232, 14–21. [Google Scholar] [CrossRef]
  51. Rabello, B.R.; Gerola, A.P.; Pellosi, D.S.; Tessaro, A.L.; Aparício, J.L.; Caetano, W.; Hioka, N. Singlet Oxygen Dosimetry Using Uric Acid as a Chemical Probe: Systematic Evaluation. J. Photochem. Photobiol. A Chem. 2012, 238, 53–62. [Google Scholar] [CrossRef]
  52. Li, L.; Ni, R.; Shao, Y.; Mao, S. Carrageenan and Its Applications in Drug Delivery. Carbohydr. Polym. 2014, 103, 1–11. [Google Scholar] [CrossRef]
  53. Neamtu, B.; Barbu, A.; Negrea, M.O.; Berghea-Neamțu, C.S.; Popescu, D.; Zăhan, M.; Mireșan, V. Carrageenan-Based Compounds as Wound Healing Materials. Int. J. Mol. Sci. 2022, 23, 9117. [Google Scholar] [CrossRef]
  54. Tadros, T.; Izquierdo, P.; Esquena, J.; Solans, C. Formation and Stability of Nano-Emulsions. Adv. Colloid Interface Sci. 2004, 109, 303–318. [Google Scholar] [CrossRef]
  55. Pre-proofs, J. Modeling Droplets Swelling and Escape in Double Emulsions Using Population Balance Equations. Chem. Eng. J. 2004, 108-109, 303–318. [Google Scholar] [CrossRef]
  56. Bui, V.T.N.T.; Nguyen, B.T.; Nicolai, T.; Renou, F. Mixed Iota and Kappa Carrageenan Gels in the Presence of Both Calcium and Potassium Ions. Carbohydr. Polym. 2019, 223, 115107. [Google Scholar] [CrossRef]
  57. Chen, J.; Chen, W.; Duan, F.; Tang, Q.; Li, X.; Zeng, L.; Zhang, J.; Xing, Z.; Dong, Y.; Jia, L.; et al. The Synergistic Gelation of Okra Polysaccharides with Kappa-Carrageenan and Its Influence on Gel Rheology, Texture Behaviour and Microstructures. Food Hydrocoll. 2019, 87, 425–435. [Google Scholar] [CrossRef]
  58. Namjoshi, S.; Dabbaghi, M.; Roberts, M.S.; Grice, J.E.; Mohammed, Y. Quality by Design: Development of the Quality Target Product Profile (QTPP) for Semisolid Topical Products. Pharmaceutics 2020, 12, 287. [Google Scholar] [CrossRef] [PubMed]
  59. Osmałek, T.; Milanowski, B.; Froelich, A.; Górska, S.; Białas, W.; Szybowicz, M.; Kapela, M. Novel Organogels for Topical Delivery of Naproxen: Design, Physicochemical Characteristics and in Vitro Drug Permeation. Pharm. Dev. Technol. 2017, 22, 521–536. [Google Scholar] [CrossRef] [PubMed]
  60. Amasya, G.; Karavana, S.Y.; Şen, T.; Baloǧlu, E.; Tarimci, N. Bioadhesive and Mechanical Properties of Triamcinolone Acetonide Buccal Gels. Turkish J. Pharm. Sci. 2012, 9, 1–10. [Google Scholar]
  61. Borghi-Pangoni, F.B.; Junqueira, M.V.; Barbosa, S.; Ferreira, D.S.; Silva, L.L.; Rabello, B.R.; Caetano, W.; Diniz, A.; Bruschi, M.L. Screening and In Vitro Evaluation of Mucoadhesive Thermoresponsive System Containing Methylene Blue for Local Photodynamic Therapy of Colorectal Cancer. Pharm. Res. 2015, 33, 776–791. [Google Scholar] [CrossRef] [PubMed]
  62. Junqueira, M.V.; Borghi-Pangoni, F.B.; Ferreira, S.B.S.; Rabello, B.R.; Hioka, N.; Bruschi, M.L. Functional Polymeric Systems as Delivery Vehicles for Methylene Blue in Photodynamic Therapy. Langmuir 2016, 32, 19–27. [Google Scholar] [CrossRef]
  63. Jones, D.S.; Bruschi, M.L.; de Freitas, O.; Gremião, M.P.D.; Lara, E.H.G.; Andrews, G.P. Rheological, Mechanical and Mucoadhesive Properties of Thermoresponsive, Bioadhesive Binary Mixtures Composed of Poloxamer 407 and Carbopol 974P Designed as Platforms for Implantable Drug Delivery Systems for Use in the Oral Cavity. Int. J. Pharm. 2009, 372, 49–58. [Google Scholar] [CrossRef]
  64. Cristini, V.; Guido, S.; Alfani, A.; Bławzdziewicz, J.; Loewenberg, M. Drop Breakup and Fragment Size Distribution in Shear Flow. J. Rheol. 2003, 47, 1283–1298. [Google Scholar] [CrossRef] [Green Version]
  65. Tsakalos, V.T.; Navard, P.; Peuvrel-Disdier, E. Deformation and Breakup Mechanisms of Single Drops during Shear. J. Rheol. 1998, 42, 1403–1417. [Google Scholar] [CrossRef]
  66. Barai, N.; Mandal, N. Breakup Modes of Fluid Drops in Confined Shear Flows. Phys. Fluids 2016, 28, 073302. [Google Scholar] [CrossRef]
  67. dos Santos, R.S.; da Silva, J.B.; Rosseto, H.C.; Vecchi, C.F.; Campanholi, K.D.S.S.; Caetano, W.; Bruschi, M.L. Emulgels Containing Propolis and Curcumin: The Effect of Type of Vegetable Oil, Poly(Acrylic Acid) and Bioactive Agent on Physicochemical Stability, Mechanical and Rheological Properties. Gels 2021, 7, 120. [Google Scholar] [CrossRef]
  68. Langendorff, V.; Cuvelier, G.; Launay, B.; Michon, C.; Parker, A.; De Kruif, C.G. Casein Micelle/Iota Carrageenan Interactions in Milk: Influence of Temperature. Food Hydrocoll. 1999, 13, 211–218. [Google Scholar] [CrossRef]
  69. Dabbaghi, M.; Namjoshi, S.; Panchal, B.; Grice, J.E.; Prakash, S.; Roberts, M.S.; Mohammed, Y. Viscoelastic and Deformation Characteristics of Structurally Different Commercial Topical Systems. Pharmaceutics 2021, 13, 1351. [Google Scholar] [CrossRef]
  70. Andrews, G.P.; Laverty, T.P.; Jones, D.S. Mucoadhesive Polymeric Platforms for Controlled Drug Delivery. Eur. J. Pharm. Biopharm. 2009, 71, 505–518. [Google Scholar] [CrossRef]
  71. Baloglu, E.; Karavana, S.Y.; Senyigit, Z.A.; Guneri, T. Rheological and Mechanical Properties of Poloxamer Mixtures as a Mucoadhesive Gel Base. Pharm. Dev. Technol. 2011, 16, 627–636. [Google Scholar] [CrossRef] [PubMed]
  72. Ferreira, S.B.D.S.; Da Silva, J.B.; Borghi-Pangoni, F.B.; Junqueira, M.V.; Bruschi, M.L. Linear Correlation between Rheological, Mechanical and Mucoadhesive Properties of Polycarbophil Polymer Blends for Biomedical Applications. J. Mech. Behav. Biomed. Mater. 2017, 68, 265–275. [Google Scholar] [CrossRef]
  73. Ferreira, S.B.D.S.; Moço, T.D.; Borghi-Pangoni, F.B.; Junqueira, M.V.; Bruschi, M.L. Rheological, Mucoadhesive and Textural Properties of Thermoresponsive Polymer Blends for Biomedical Applications. J. Mech. Behav. Biomed. Mater. 2016, 55, 164–178. [Google Scholar] [CrossRef]
  74. Bruschi, M.L.; Jones, D.S.; Panzeri, H.; Gremião, M.P.D.; De Freitas, O.; Lara, E.H.G. Semisolid Systems Containing Propolis for the Treatment of Periodontal Disease: In Vitro Release Kinetics, Syringeability, Rheological, Textural, and Mucoadhesive Properties. J. Pharm. Sci. 2007, 96, 2074–2089. [Google Scholar] [CrossRef]
  75. Vangeel, I.; Pasmans, F.; Vanrobaeys, M.; de Herdt, P.; Haesebrouck, F. Prevalence of Dermatophytes in Asymptomatic Guinea Pigs and Rabbits. Vet. Rec. 2000, 146, 440–441. [Google Scholar] [CrossRef]
  76. Harcourt-Brown, F. Skin Diseases. In Textbook of Rabbit Medicine; Harcourt-Brown, F.E., Ed.; Butterworth-Heinemann: Oxford, UK, 2002; pp. 233–240. [Google Scholar]
  77. Brychcy, E.; Malik, M.; Drozdzewski, P.; Król, Z.; Jarmoluk, A. Physicochemical and Antibacterial Properties of Carrageenan and Gelatine Hydrosols and Hydrogels Incorporated with Acidic Electrolyzed Water. Polymers 2015, 7, 2638–2649. [Google Scholar] [CrossRef]
  78. Combuca, R.; Campanholi, K.d.S.S.; Caetano, W.; Pozza, M.S.d.S. Géis e Hidrogéis Fotoativos Contribuem Para Minimizar a Geração de Resíduos Na Produção Leiteira. Bioika 2020, 3191, 1–5. [Google Scholar]
  79. Martignago, C.C.S.; Tim, C.R.; Assis, L.; Da Silva, V.R.; Dos Santos, E.C.B.; Vieira, F.N.; Parizotto, N.A.; Liebano, R.E. Effects of Red and Near-Infrared LED Light Therapy on Full-Thickness Skin Graft in Rats. Lasers Med. Sci. 2020, 35, 157–164. [Google Scholar] [CrossRef]
  80. Noreen, S.; Pervaiz, F.; Ashames, A.; Buabeid, M.; Fahelelbom, K.; Shoukat, H.; Maqbool, I.; Murtaza, G. Optimization of Novel Naproxen-Loaded Chitosan/ Carrageenan Nanocarrier-Based Gel for Topical Delivery: Ex Vivo, Histopathological, and in Vivo Evaluation. Pharmaceuticals 2021, 14, 557. [Google Scholar] [CrossRef]
  81. de Almeida Lucas, F.; Kandrotas, A.L.; Neto, E.N.; de Siqueira, C.E.; André, G.S.; Bromerschenkel, I.; Perri, S.H.V. Copaiba Oil in Experimental Wound Healing in Horses. Ciência Rural 2017, 47, 1–7. [Google Scholar] [CrossRef]
  82. Paranhos, S.B.; da Sliva Ferreira, E.; Canelas, C.A.d.A.; da Paz, S.P.A.; Passos, M.F.; da Costa, C.E.F.; da Silva, A.C.R.; Monteiro, S.N.; Candido, V.S. Chitosan Membrane Containing Copaiba Oil (Copaifera Spp.) for Skin Wound Treatment. Polymers 2021, 14, 35. [Google Scholar] [CrossRef]
  83. Abou El-ezz, D.; Abdel-Rahman, L.H.; Al-Farhan, B.S.; Mostafa, D.A.; Ayad, E.G.; Basha, M.T.; Abdelaziz, M.; Abdalla, E.M. Enhanced In Vivo Wound Healing Efficacy of a Novel Hydrogel Loaded with Copper (II) Schiff Base Quinoline Complex (CuSQ) Solid Lipid Nanoparticles. Pharmaceuticals 2022, 15, 978. [Google Scholar] [CrossRef] [PubMed]
  84. Lam, C.R.; Brush, B.E. Chlorophyll and Wound Healing. Am. J. Surg. 1950, 80, 204–210. [Google Scholar] [CrossRef]
  85. Smith, L.W.; Livingston, A.E. Wound Healing: An Experimental Study of Water Soluble Chlorophyll Derivatives in Conjunction with Various Antibacterial Agents. Am. J. Surg. 1945, 67, 30–39. [Google Scholar] [CrossRef]
  86. Polat, E.; Kang, K. Natural Photosensitizers in Antimicrobial Photodynamic Therapy. Biomedicines 2021, 9, 584. [Google Scholar] [CrossRef]
  87. Núñez-Álvarez, C.; Osborne, N.N. Enhancement of Corneal Epithelium Cell Survival, Proliferation and Migration by Red Light: Relevance to Corneal Wound Healing. Exp. Eye Res. 2019, 180, 231–241. [Google Scholar] [CrossRef]
  88. Chen, X.; Zhou, Y.; Huang, J.; An, D.; Li, L.; Dong, Y.; Gao, Q.; Dong, S. The Effects of Blue and Red Light Color Combinations on the Growth and Immune Performance of Juvenile Steelhead Trout, Oncorhynchus Mykiss. Aquac. Rep. 2022, 24, 1–8. [Google Scholar] [CrossRef]
  89. Liebert, A.; Bicknell, B.; Markman, W.; Kiat, H. A Potential Role for Photobiomodulation Therapy in Disease Treatment and Prevention in the Era of COVID-19. Aging Dis. 2020, 11, 1352–1362. [Google Scholar] [CrossRef] [PubMed]
Pharmaceutics 14 02580 g001 550
Figure 1. Obtaining the formulation composed of k-car, F127, chlorophylls, and CO, making up the Phy-CO-Chl emulgel.
Figure 1. Obtaining the formulation composed of k-car, F127, chlorophylls, and CO, making up the Phy-CO-Chl emulgel.
Pharmaceutics 14 02580 g001
Pharmaceutics 14 02580 g002 550
Figure 2. Illumination of Phy-Chl and Phy-CO-Chl gels.
Figure 2. Illumination of Phy-Chl and Phy-CO-Chl gels.
Pharmaceutics 14 02580 g002
Pharmaceutics 14 02580 g003 550
Figure 3. Gel administration and animal-illumination process.
Figure 3. Gel administration and animal-illumination process.
Pharmaceutics 14 02580 g003
Pharmaceutics 14 02580 g004 550
Figure 4. Spectral irradiance at 2.5 cm using different currents (A), and irradiance data linear correlations (insert); (B) spectral overlap between chlorophyll absorption and light source emission (normalized spectra).
Figure 4. Spectral irradiance at 2.5 cm using different currents (A), and irradiance data linear correlations (insert); (B) spectral overlap between chlorophyll absorption and light source emission (normalized spectra).
Pharmaceutics 14 02580 g004
Pharmaceutics 14 02580 g005 550
Figure 5. The normalized electronic absorption spectra for Spirulina sp. and purified Chls (A); and solution of Spirulina sp. 4 mg/mL and 29 μmol/L of UA in ethanol (B), under 70 min illumination with red light.
Figure 5. The normalized electronic absorption spectra for Spirulina sp. and purified Chls (A); and solution of Spirulina sp. 4 mg/mL and 29 μmol/L of UA in ethanol (B), under 70 min illumination with red light.
Pharmaceutics 14 02580 g005
Pharmaceutics 14 02580 g006 550
Figure 6. Photograph of the obtained k-car-based formulations. Std-gel corresponds to the polymer blend without drugs; Phy-Chl is the polymer base containing Chls, Phy-CO contains copaiba oil, and Phy-CO-Chl contains copaiba oil and Chls. The magnification represents the microstructure of the Phy-CO-Chl formulation.
Figure 6. Photograph of the obtained k-car-based formulations. Std-gel corresponds to the polymer blend without drugs; Phy-Chl is the polymer base containing Chls, Phy-CO contains copaiba oil, and Phy-CO-Chl contains copaiba oil and Chls. The magnification represents the microstructure of the Phy-CO-Chl formulation.
Pharmaceutics 14 02580 g006
Pharmaceutics 14 02580 g007 550
Figure 7. Phy-gels continuous flow rheograms at 32.0 °C (A,B). Standard deviations were omitted for clarity; however, the coefficient of variation of the replicate analyzes was <10% in all cases.
Figure 7. Phy-gels continuous flow rheograms at 32.0 °C (A,B). Standard deviations were omitted for clarity; however, the coefficient of variation of the replicate analyzes was <10% in all cases.
Pharmaceutics 14 02580 g007
Pharmaceutics 14 02580 g008 550
Figure 8. Viscoelastic properties of the gel formulations as a function of temperature: (A) storage modulus (G’) and (B) dynamic viscosity. The marking in (B) corresponds to the variation between temperatures of 25 °C (room temperature) and 32 °C (skin temperature). Standard deviations were omitted for clarity; however, the coefficient of variation of the replicate analyzes was <10% in all cases.
Figure 8. Viscoelastic properties of the gel formulations as a function of temperature: (A) storage modulus (G’) and (B) dynamic viscosity. The marking in (B) corresponds to the variation between temperatures of 25 °C (room temperature) and 32 °C (skin temperature). Standard deviations were omitted for clarity; however, the coefficient of variation of the replicate analyzes was <10% in all cases.
Pharmaceutics 14 02580 g008
Pharmaceutics 14 02580 g009a 550Pharmaceutics 14 02580 g009b 550
Figure 9. Gel oscillatory properties at 32.0 °C, being (A,B) G’ (elastic) and G” (viscous) moduli, (C) dynamic viscosity, and (D) viscoelasticity properties as a function of oscillatory frequency.
Figure 9. Gel oscillatory properties at 32.0 °C, being (A,B) G’ (elastic) and G” (viscous) moduli, (C) dynamic viscosity, and (D) viscoelasticity properties as a function of oscillatory frequency.
Pharmaceutics 14 02580 g009aPharmaceutics 14 02580 g009b
Pharmaceutics 14 02580 g010 550
Figure 10. Inactivation of S. aureus by a set of phytotherapeutic gels applied to PDT. The absence of bars indicates the complete elimination of the microbial load.
Figure 10. Inactivation of S. aureus by a set of phytotherapeutic gels applied to PDT. The absence of bars indicates the complete elimination of the microbial load.
Pharmaceutics 14 02580 g010
Pharmaceutics 14 02580 g011 550
Figure 11. (A) Macroscopical aspects of the plantar face of feet in rabbit breeders during control treatment. (B) Histological appearance on the lesion areas in the last day of treatment with iodine. The arrow in the photo indicates the border of the wound. The wound area surface was characterized by debris and exudate (ex), and a concentration of polymorphonuclear and inflammatory cells (inf) in the dermis. (C) Photomicrographs of histological aspects of untreated wounds. (B,C) Paraffin section, HE.
Figure 11. (A) Macroscopical aspects of the plantar face of feet in rabbit breeders during control treatment. (B) Histological appearance on the lesion areas in the last day of treatment with iodine. The arrow in the photo indicates the border of the wound. The wound area surface was characterized by debris and exudate (ex), and a concentration of polymorphonuclear and inflammatory cells (inf) in the dermis. (C) Photomicrographs of histological aspects of untreated wounds. (B,C) Paraffin section, HE.
Pharmaceutics 14 02580 g011
Pharmaceutics 14 02580 g012 550
Figure 12. (A,C) Macroscopical aspects of the plantar face of feet in rabbits during Phy-CO and Phy-Chl (dark, without PDT use) treatment. (B,D) Histology of the last day of each treatment. The arrow from the photo of the feet indicates that the paw was analyzed histologically. The images show the keratin layer (ke), the stratified keratinized epithelium (ep), collagen presence (col), hair follicles (fol), blood vessels (ve), and signs of inflammation (inf). (B–D) Paraffin section, HE.
Figure 12. (A,C) Macroscopical aspects of the plantar face of feet in rabbits during Phy-CO and Phy-Chl (dark, without PDT use) treatment. (B,D) Histology of the last day of each treatment. The arrow from the photo of the feet indicates that the paw was analyzed histologically. The images show the keratin layer (ke), the stratified keratinized epithelium (ep), collagen presence (col), hair follicles (fol), blood vessels (ve), and signs of inflammation (inf). (B–D) Paraffin section, HE.
Pharmaceutics 14 02580 g012
Pharmaceutics 14 02580 g013 550
Figure 13. (A) Macroscopical aspects of the plantar face of feet in rabbits during the Phy-CO-Chl treatment, without PDT use. The arrow in the photo of the feet indicates that the paw was analyzed histologically. (B) Histological aspect of skin in the last day of treatment (paraffin section, HE). The images show the keratin layer (ke) and the presence of tissue vascularization (ve).
Figure 13. (A) Macroscopical aspects of the plantar face of feet in rabbits during the Phy-CO-Chl treatment, without PDT use. The arrow in the photo of the feet indicates that the paw was analyzed histologically. (B) Histological aspect of skin in the last day of treatment (paraffin section, HE). The images show the keratin layer (ke) and the presence of tissue vascularization (ve).
Pharmaceutics 14 02580 g013
Pharmaceutics 14 02580 g014 550
Figure 14. (A,C) Macroscopical aspects of the plantar face of feet in rabbits during Phy-Chl and Phy-CO-Chl (light, with PDT use) treatment. (B,D) Histology in the last day of treatment, evidencing the dermic papillae (dp), the keratin layer (ke), the stratified keratinized epithelium (ep), wound crust, the presence of vascularization of the tissue (ve), the presence of collagen (col), and hair follicles (fol).
Figure 14. (A,C) Macroscopical aspects of the plantar face of feet in rabbits during Phy-Chl and Phy-CO-Chl (light, with PDT use) treatment. (B,D) Histology in the last day of treatment, evidencing the dermic papillae (dp), the keratin layer (ke), the stratified keratinized epithelium (ep), wound crust, the presence of vascularization of the tissue (ve), the presence of collagen (col), and hair follicles (fol).
Pharmaceutics 14 02580 g014
Table
Table 1. Composition of the topical formulations.
Table 1. Composition of the topical formulations.
CompositionFormulations (%, w/w)
Gel-StdPhy-ChlPhy-COPhy-Chl-CO
Carrageenan2.02.02.02.0
F1274.04.04.04.0
Spirulina sp.00.500.5
Copaifera reticulata (CO)004.04.0
Purified water 9493.59089.5
Table
Table 2. Rabbits’ treatment groups.
Table 2. Rabbits’ treatment groups.
Treatment Group
DarkPhy-Chl
Phy-CO
Phy-CO-Chl
Iodine 10 %, m/V (control)
LightPhy-Chl
Phy-CO-Chl
Table
Table 3. Textural mechanical characteristics (hardness, adhesiveness, elasticity, cohesiveness, and compressibility) of gel formulations (mean ± standard deviation).
Table 3. Textural mechanical characteristics (hardness, adhesiveness, elasticity, cohesiveness, and compressibility) of gel formulations (mean ± standard deviation).
ParameterStd-GelPhy-ChlPhy-COPhy-CO-Chl
Hardness (N)0.238 ± 0.0090.149 ± 0.0050.184 ± 0.0040.171 ± 0.025
Adhesiveness (N.mm)1.033 ± 0.1270.681 ± 0.0480.919 ± 0.0320.881 ± 0.047
Elasticity (mm)1.001 ± 0.0031.002 ± 0.0050.999 ± 0.0031.001 ± 0.005
Cohesiveness (dimensionless)0.647 ± 0.0630.742 ± 0.0230.680 ± 0.0110.695 ± 0.034
Compressibility (N.mm) 2.404 ± 0.1881.472 ± 0.1162.050 ± 0.0751.863 ± 0.238
Table
Table 4. The mechanical properties of commercial gel formulations.
Table 4. The mechanical properties of commercial gel formulations.
ParameterValuesCommercial GelReference
Hardness (N)0.41 ± 0.02Emo®[59]
0.15 ± 0.01Opokan®[59]
Adhesiveness (N.mm)0.57 ± 0.06Opokan®[59]
Elasticity (mm)0.96 ± 0.06Kenacort-A Orabase®[60]
Cohesiveness (dimensionless)0.83 ± 0.04Emo®[59]
Compressibility (N.mm) 1.92 ± 0.13Kenacort-A Orabase®[60]
Table
Table 5. Consistency index (K), flow behavior (n), and yield value (σy) obtained with upward flow curve modeled by Ostwald–de Waele and Casson equations.
Table 5. Consistency index (K), flow behavior (n), and yield value (σy) obtained with upward flow curve modeled by Ostwald–de Waele and Casson equations.
Rheological ParametersK (Pa.s)nn (Dimensionless)σy (Pa)
Std-gel37.51 ± 2.700.32 ± 0.02127.65 ± 10.02
Phy-Chl18.90 ± 2.270.40 ± 0.0082.80 ± 8.97
Phy-CO30.29 ± 2.920.39 ± 0.01130.67 ± 17.14
Phy-CO-Chl22.72 ± 6.880.34 ± 0.05106.66 ± 33.41
Table
Table 6. Average lesions (percentages) contraction between the 1st and 21st day, considering six legs for each treatment.
Table 6. Average lesions (percentages) contraction between the 1st and 21st day, considering six legs for each treatment.
Treatment% Wound Contraction
Phy-Chl86.0 aDark
Phy-CO100.0 a
Phy-Chl-CO59.5 a
Phy-Chl87.0 aLight
Phy-Chl-CO84.0 a
Iodine control−78.3 ab
Equal letters are equivalent to p > 0.05, and different letters to p < 0.05.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Campanholi, K.d.S.S.; da Silva Junior, R.C.; Gonçalves, R.S.; de Oliveira, M.C.; Pozza, M.S.d.S.; Leite, A.T.; da Silva, L.H.; Malacarne, L.C.; Bruschi, M.L.; Castilha, L.D.; et al. Photo-Phytotherapeutic Gel Composed of Copaifera reticulata, Chlorophylls, and k-Carrageenan: A New Perspective for Topical Healing. Pharmaceutics 2022, 14, 2580. https://doi.org/10.3390/pharmaceutics14122580

AMA Style

Campanholi KdSS, da Silva Junior RC, Gonçalves RS, de Oliveira MC, Pozza MSdS, Leite AT, da Silva LH, Malacarne LC, Bruschi ML, Castilha LD, et al. Photo-Phytotherapeutic Gel Composed of Copaifera reticulata, Chlorophylls, and k-Carrageenan: A New Perspective for Topical Healing. Pharmaceutics. 2022; 14(12):2580. https://doi.org/10.3390/pharmaceutics14122580

Chicago/Turabian Style

Campanholi, Katieli da Silva Souza, Ranulfo Combuca da Silva Junior, Renato Sonchini Gonçalves, Mariana Carla de Oliveira, Magali Soares dos Santos Pozza, Angela Tiago Leite, Leandro Herculano da Silva, Luis Carlos Malacarne, Marcos Luciano Bruschi, Leandro Dalcin Castilha, and et al. 2022. "Photo-Phytotherapeutic Gel Composed of Copaifera reticulata, Chlorophylls, and k-Carrageenan: A New Perspective for Topical Healing" Pharmaceutics 14, no. 12: 2580. https://doi.org/10.3390/pharmaceutics14122580

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop